Clarify Health Solutions closed $57 million in a series B financing round led by global investment firm KKR.
Clarify plans to use the new funding to expand its clinical transformation, sales, engineering, and data science teams, to acquire new data assets and to accelerate the development of its digital care guidance platform. This will help build upon the company’s rapid customer expansion in 2018 and fuel its growth.
“We are thrilled to partner with KKR to build the world’s first real-time care guidance platform,” said Dr. Jean Drouin, MD, CEO and co-founder of Clarify. “We are entering a new era, where technology can help us to reimagine care delivery. We have accepted for far too long that an accessible, service-oriented and customer-centric experience is simply unattainable in health care. We are committed to making the words ‘delightful,’ ‘healed,’ and ‘affordable’ far more common in the health care lexicon.”
The investment is being funded through KKR’s Health Care Strategic Growth Fund, which is focused on investing in high-growth health care-related companies and helping them reach scale.
“Today’s health care market is not only very complicated but also extremely fragmented and marked by patient dissatisfaction,” said Ali Satvat, head of KKR’s Health Care Strategic Growth investing efforts. “The impressive and highly experienced team at Clarify is addressing this problem by bringing the power of technology to the industry in a way in which it has not been applied to date. We are delighted to partner with Clarify on this effort to enable a more effective, efficient, and simply better health care experience for both physicians and the patients who need it.”
Clarify, a pioneer in real-time care guidance technology, provides financial services and consumer technologies to hospital, health insurance and life sciences customers, along with the clinical expertise needed to power innovative care delivery models.
